Open Access
Enhancer Remodeling during Adaptive Bypass to MEK Inhibition Is Attenuated by Pharmacologic Targeting of the P-TEFb Complex
Author(s) -
Jon S. Zawistowski,
Samantha M. Bevill,
Daniel R. Goulet,
Timothy J. Stuhlmiller,
Adriana S. Beltrán,
José F. Olivares-Quintero,
Darshan Singh,
Noah Sciaky,
Joel S. Parker,
Naim U. Rashid,
Xin Chen,
James S. Duncan,
Martin C. Whittle,
Steven P. Angus,
Sara H. Velarde,
Brian T. Golitz,
Xiaping He,
Charlene Santos,
David B. Darr,
Kristalyn Gallagher,
Lee M. Graves,
Charles M. Perou,
Lisa A. Carey,
Shelton Earp,
Gary L. Johnson
Publication year - 2017
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/gqcg-ne46
Subject(s) - enhancer , p tefb , medicine , chemistry , biology , genetics , gene , gene expression , promoter